All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • NP-G2-044PrilukaePhase 32 trials

    Novita Pharmaceuticals, Inc. · Platinum-resistant Ovarian Cancer, Advanced or Metastatic Solid Tumor Malignancies

  • NRTX-1001GABA-secreting interneuronsPhase 32 trials

    Neurona Therapeutics · Epilepsy, Temporal Lobe, Mesial Temporal Lobe Epilepsy

  • NTLA-2001nexiguran ziclumeranPhase 32 trials

    Intellia Therapeutics · Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease

  • NucresiranALN-TTRSC04Phase 32 trials

    Alnylam Pharmaceuticals · Transthyretin Amyloidosis With Cardiomyopathy, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN

  • NuvastaticPhase 32 trials

    Natureceuticals Sdn Bhd · Fatigue, Colon Cancer, Breast Neoplasms

  • Nuvastatic 300Phase 32 trials

    Natureceuticals Sdn Bhd · Fatigue Related to Cancer Treatment, Colon Cancer, Breast Cancer

  • NVG-291Phase 32 trials

    NervGen Pharma · Chronic Spinal Cord Injury, Spinal Cord Injuries, Subacute Spinal Cord Injury

  • NXT007Zemocimig, RO7589655Phase 32 trials

    Roche (Genentech) · Hemophilia A

  • OBI-821OBI-833Phase 32 trials

    OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer

  • OBRPhase 32 trials

    Gilead Sciences · HIV-1-infection

  • OciperlimabBGB-A1217Phase 32 trials

    BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies

  • OCS-01Phase 32 trials

    Oculis · Diabetic Macular Edema

  • of Physician's ChoicePhase 32 trials

    BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm

  • OlorofimF901318Phase 32 trials

    F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection

  • OLZSAM, ALKS 3831Phase 32 trials

    Alkermes, Inc. · Bipolar I Disorder, Schizophrenia

  • ONO-2808Phase 32 trials

    Ono Pharmaceutical Co., Ltd. · Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy (MSA)

  • Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease

  • OPN-375Phase 32 trials

    Optinose US Inc. · Chronic Rhinosinusitis Without Nasal Polyps, Bilateral Nasal Polyposis

  • OSE2101Phase 32 trials

    OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma

  • PalazestrantOP-1250Phase 32 trials

    Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer

  • PamiparibBGB-290Phase 32 trials

    BeOne Medicines (BeiGene) · Ovarian Cancer, Advanced Malignancies

  • PBOPhase 32 trials

    SK Life Science, Inc. · Primary Generalized Epilepsy, Treatment Resistant Depression

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • PF-08046054SGN-PDL1VPhase 32 trials

    Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

  • phentolamine vehiclePhase 32 trials

    Opus Genetics, Inc · Mesopic Vision, Night Vision Loss, Presbyopia

  • PicankibartPhase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis

  • piclidenosonPhase 32 trials

    Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome

  • pMDI HFA-152aCHF5993 100, CHF5993 200Phase 32 trials

    Chiesi Farmaceutici S.p.A. · Asthma

  • PORT-77Phase 32 trials

    Portal Therapeutics, Inc. · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2

  • Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials

    EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer

  • PridopidinePhase 32 trials

    Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease

  • PTM FPhase 32 trials

    Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection

  • PTM LENPhase 32 trials

    Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection

  • PTX-022Phase 32 trials

    Palvella Therapeutics, Inc. · Angiokeratomas, Pachyonychia Congenita

  • pudexacianinium chlorideASP5354Phase 32 trials

    Astellas · Intraoperative Ureter Visualization, Abdominolpelvic Surgery

  • Purinostat MesylatePhase 32 trials

    Chengdu Zenitar Biomedical Technology Co., Ltd · Relapsed or Refractory Multiple Myeloma (RRMM), Recurrent and Refractory Diffuse Large B-cell Lymphoma

  • Tasly Pharmaceutical Group Co., Ltd · Heart Failure, Chronic Heart Failure With Preserved Ejection Fraction

  • QL0911Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune

  • QLS32015Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Relapsed or Refractory Multiple Myeloma

  • QLS4131Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma

  • QRX-3EseronatePhase 32 trials

    Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure

  • Palvella Therapeutics, Inc. · Cutaneous Venous Malformations, Microcystic Lymphatic Malformation

  • RadiprodilPhase 32 trials

    GRIN Therapeutics, Inc. · GRIN-related Neurodevelopmental Disorder, Tuberous Sclerosis Complex, Focal Cortical Dysplasia

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • RC118RC118-ADCPhase 32 trials

    RemeGen Co., Ltd. · Advanced Solid Tumor, Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  • Reference DrugNSAIDsPhase 32 trials

    SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis

  • Sun Pharmaceutical Industries, Inc. · Actinic Keratosis

  • REGEND001Phase 32 trials

    Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis

  • REGN1908FreneslerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN1909MevonlerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

NewerPage 17 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.